Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients

作者：Ren, Changhong; Kobeissy, Firas; Alawieh, Ali; Li, Na; Li, Ning; Zibara, Kazem; Zoltewicz, Susie; Guingab-Cagmat, Joy; Larner, Stephen F.; Ding, Yuchuan; Hayes, Ronald L.; Ji, Xunming^*; Mondello, Stefania^*

来源：Scientific Reports, 2016, 6(1): 24588.

DOI：10.1038/srep24588

• TRAUMATIC BRAIN-INJURY
• FIBRILLARY ACIDIC PROTEIN
• C-TERMINAL HYDROLASE-L1
• HEALTH-CARE PROFESSIONALS
• ACUTE ISCHEMIC-STROKE
• INTRACEREBRAL HEMORRHAGE
• NEUROSURGICAL INTERVENTION
• INTRACRANIAL LESIONS
• COMPUTED-TOMOGRAPHY
• BIOMARKERS

A rapid and reliable diagnostic test to distinguish ischemic from hemorrhagic stroke in patients presenting with stroke-like symptoms is essential to optimize management and triage for thrombolytic therapy. The present study measured serum concentrations of ubiquitin C-terminal hydrolase (UCH-L1) and glial fibrillary astrocytic protein (GFAP) in acute stroke patients and healthy controls and investigated their relation to stroke severity and patient characteristics. We also assessed the diagnostic performance of these markers for the differentiation of intracerebral hemorrhage (ICH) from ischemic stroke (IS). Both UCH-L1 and GFAP concentrations were significantly greater in ICH patients than in controls (p < 0.0001). However, exclusively GFAP differed in ICH compared with IS (p < 0.0001). GFAP yielded an AUC of 0.86 for differentiating between ICH and IS within 4.5hrs of symptom onset with a sensitivity of 61% and a specificity of 96% using a cut-off of 0.34ng/ml. Higher GFAP levels were associated with stroke severity and history of prior stroke. Our results demonstrate that blood UCH-L1 and GFAP are increased early after stroke and distinct biomarker-specific release profiles are associated with stroke characteristics and type. We also confirmed the potential of GFAP as a tool for early rule-in of ICH, while UCH-L1 was not clinically useful.

• 出版日期2016-4-14
• 单位首都医科大学